STAT February 9, 2023
Jonathan Wosen

Researchers who believe genomics can transform human health love to recount success stories. They’ll tell you about the 3-month-old boy whose heart was failing until researchers pinpointed what was ailing him. Or the baby girl who could have had a life-threatening reaction to anesthesia had researchers not sequenced her DNA ahead of time.

But a new study focuses on a much more somber set of stories: those of infants who died with genetic diseases and who in some cases could have been treated, perhaps even saved.

When researchers at Rady Children’s Institute for Genomic Medicine in San Diego examined the DNA sequencing data of 112 infants who had died, they found genetic diseases in 40% of these cases. For 30%...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider, Survey / Study, Trends
Age of Opportunity: Artificial Intelligence and the Precision Medicine Future
Opinion: Readers respond to OTC antidepressants, personalized medicine, restoring trust in public health, and more
Precision medicine approach combining AI, DNA and drug testing shows gains against relapsed childhood cancers
Precision Diagnostics Can Save Money In Healthcare: What’s Holding Them Back?
Personalized Medicine Revolution: Coding, Documentation, and Reimbursement in the Genomic Era

Share This Article